Literature DB >> 1674152

Drugs, sex and HIV: a mathematical model for New York City.

S M Blower1, D Hartel, H Dowlatabadi, R M Anderson, R M May.   

Abstract

A data-based mathematical model was formulated to assess the epidemiological consequences of heterosexual, intravenous drug use (IVDU) and perinatal transmission in New York City (NYC). The model was analysed to clarify the relationship between heterosexual and IVDU transmission and to provide qualitative and quantitative insights into the HIV epidemic in NYC. The results demonstrated the significance of the dynamic interaction of heterosexual and IVDU transmission. Scenario analysis of the model was used to suggest a new explanation for the stabilization of the seroprevalence level that has been observed in the NYC IVDU community; the proposed explanation does not rely upon any IVDU or sexual behavioural changes. Gender-specific risks of heterosexual transmission in IVDUs were also explored by scenario analysis. The results showed that the effect of the heterosexual transmission risk factor on increasing the risk of HIV infection depends upon the level of IVDU. The model was used to predict future numbers of adult and pediatric AIDS cases; a sensitivity analysis of the model showed that the confidence intervals on these prediction estimates were extremely wide. This prediction variability was due to the uncertainty in estimating the values of the models' thirty variables (twenty biological-behavioural transmission parameters and the initial sizes of ten subgroups). However, the sensitivity analysis revealed that only a few key variables were significant in contributing to the AIDS case prediction variability; partial rank correlation coefficients were calculated and used to identify and to rank the importance of these key variables. The results suggest that long-term precise estimates of the future number of AIDS cases will only be possible once the values of these key variables have been evaluated accurately.

Entities:  

Mesh:

Year:  1991        PMID: 1674152     DOI: 10.1098/rstb.1991.0006

Source DB:  PubMed          Journal:  Philos Trans R Soc Lond B Biol Sci        ISSN: 0962-8436            Impact factor:   6.237


  29 in total

1.  HIV transmission and the cost-effectiveness of methadone maintenance.

Authors:  G S Zaric; P G Barnett; M L Brandeau
Journal:  Am J Public Health       Date:  2000-07       Impact factor: 9.308

Review 2.  AIDS policy modeling for the 21st century: an overview of key issues.

Authors:  M S Rauner; M L Brandeau
Journal:  Health Care Manag Sci       Date:  2001-09

3.  Random vs. nonrandom mixing in network epidemic models.

Authors:  Gregory S Zaric
Journal:  Health Care Manag Sci       Date:  2002-04

4.  Health and economic impacts of an HIV intervention in out of treatment substance abusers: evidence from a dynamic model.

Authors:  Anke Richter; Brett Loomis
Journal:  Health Care Manag Sci       Date:  2005-02

5.  Understanding the dynamics of Ebola epidemics.

Authors:  J Legrand; R F Grais; P Y Boelle; A J Valleron; A Flahault
Journal:  Epidemiol Infect       Date:  2006-09-26       Impact factor: 2.451

6.  Population dynamics of HIV-1 inferred from gene sequences.

Authors:  N C Grassly; P H Harvey; E C Holmes
Journal:  Genetics       Date:  1999-02       Impact factor: 4.562

7.  The consequences of uncertainty for the prediction of the effects of schistosomiasis control programmes.

Authors:  M S Chan
Journal:  Epidemiol Infect       Date:  1996-12       Impact factor: 2.451

8.  Methadone treatment protects against HIV infection: two decades of experience in the Bronx, New York City.

Authors:  D M Hartel; E E Schoenbaum
Journal:  Public Health Rep       Date:  1998-06       Impact factor: 2.792

Review 9.  HIV transmission and source-sink dynamics in sub-Saharan Africa.

Authors:  Justin T Okano; Katie Sharp; Eugenio Valdano; Laurence Palk; Sally Blower
Journal:  Lancet HIV       Date:  2020-02-14       Impact factor: 12.767

10.  Assessing the effects of drug misuse on HIV/AIDS prevalence.

Authors:  C P Bhunu; S Mushayabasa
Journal:  Theory Biosci       Date:  2012-12-06       Impact factor: 1.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.